Cytosorbents (CTSO) Enterprise Value Growth (1y) (2011 - 2026)

Cytosorbents (CTSO) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.08 Bn 175.79 Bn 6.27 Bn
2 Stryker 128.71 Bn 125.83 Bn 3.81 Bn
3 Medtronic 108.79 Bn 99.57 Bn 6.41 Bn
4 Boston Scientific 68.41 Bn 66.96 Bn 3.61 Bn
5 Edwards Lifesciences 48.34 Bn 44.67 Bn 1.29 Bn
6 GE HealthCare Technologies 28.34 Bn 26.06 Bn 1.98 Bn
7 Dexcom 28.34 Bn 27.22 Bn 750.30 Mn
8 Smith & Nephew 26.87 Bn 26.29 Bn -
9 Koninklijke Philips 25.43 Bn 22.31 Bn 2.07 Bn
10 Cytosorbents 22.59 Mn 17.79 Mn 6.13 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 63.39%
Dec 31, 2025 57.67%
Sep 30, 2025 -15.94%
Jun 30, 2025 -20.63%
Mar 31, 2025 -52.29%
Dec 31, 2024 -4.48%
Sep 30, 2024 22.24%
Jun 30, 2024 35.68%
Mar 31, 2024 54.81%
Dec 31, 2023 36.19%
Sep 30, 2023 62.93%
Jun 30, 2023 56.40%
Mar 31, 2023 55.72%
Dec 31, 2022 57.53%
Sep 30, 2022 63.06%
Jun 30, 2022 54.02%
Mar 31, 2022 37.16%
Dec 31, 2021 27.00%
Sep 30, 2021 30.62%
Jun 30, 2021 -86.85%